QueenMuntha said:
Ah, the Brave New World of Research. Where has this been all my life?
Compound Sema was my start in June 25, titrated up to 2.4 mg/weekly. The first four weeks took off quite a bit, then came the stall. A couple of months of it, in fact - nothing lost.
Then Nov 25 brought a direct move to 10 mg of Tirzepatide. Nov through Jan gave me 4 pounds.
AND at 365 pounds, there was a shit-ton to lose.
Research followed, and eventually I worked out how to get research Reta, which I began 4 weeks ago.
Right now the Tirz is stacked at 10mg/week with 4 mg of Reta, both taken together.
Well, that did it, my body loves the stack, and four weeks have taken 10 pounds off. Staying put for a while to see how it plays out.
Overall, right from starting Sema last June, the Ancillary Benefits of GLP1s have been magnificent. A few of the added bennies in my case have been:
- Bone-on-bone bilateral knee osteoarthritis: gone
- Chronic Kidney Disease markers shifted from Stage 3A down to Stage 2!!
- An over-active bladder that had reached the needing-diapers stage has healed, now totally gone--I am sure bladder inflammation is what was eliminated
- Obstructive Sleep Apnea has improved greatly, whether from the peptides or the weight loss--way less pressure is needed now
- AFib attacks went from once a week to NONE. (My Electrophysiologist cleared me last week to come back in a year, with lab numbers, episodes and EKGs all excellent)
- Food cravings have gone. A whole pack of anything holds no interest now. Fruits and vegetables are what I long for, with the cookies, candy and bagels left sitting on the counter.
- Walking without a cane is possible--one is no longer needed
- There's a new joi de vivre in my life, and running errands is actually enjoyable now.
Obesity is a disease I live with. For me, these GLP-1's are miracle drugs, and taking them for the rest of my life is fine by me, the same way Xarelto is taken for AFib. Leaving the 300's behind can't come soon enough. Hopefully by fall of 2026!
Any questions, just ask.